Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The Big Picture: Is global macro en vogue in 2014?

Wednesday, February 12, 2014

amb
Diane harrison
Diane Harrison, principal and owner of Princeton, NJ-based Panegyric Marketing, authored this article.

Global Macro may be coming back in style. Why? It’s all about the money. A leading tracker of global indices, BarclayHedge states that, simply put, global macro relies upon the flow of capital around the globe: Global macro strategies generally focus on financial instruments that are broad in scope and move based on systemic risk. Systemic risk, or market risk, is not security specific. These positions are filtered through a portfolio manager’s world view of the politics and economics of countries or regions which is based largely on an opinion of the direction these world markets will turn.

The Global Gestalt So why is 2014 likely to be a pivotal year for global macro investing? In large part because the fragility of global economic relationships has never been more pronounced. Like a balloon whose elastic surface has been stressed to the breaking point by multiple inflations, the international banking network is pushing its limits, stretched by years of intervention measures. These fiscal actions have led to a general weakening throughout the system that leaves it prey to any gyration of the wheel on which governments have kept it spinning since 2008.

As in most opportunities, knowing what to look for and what to do about situations is vital to success in global mac......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner